HI SCR100 | 2022 | Regular Session

Note: Carry Over of previous SCR100

Status

Spectrum: Partisan Bill (Democrat 10-0)
Status: Engrossed on March 31 2022 - 50% progression, died in committee
Action: 2022-04-19 - Report adopted; referred to the committee(s) on CPC with Representative(s) Branco voting aye with reservations; none voting no (0) and Representative(s) Hashimoto, McKelvey, Ward excused (3).
Pending: House Consumer Protection & Commerce Committee
Text: Latest bill text (Amended) [HTML]

Summary

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

Sponsors


Roll Calls

2022-04-14 - House - House Health, Human Services, & Homelessness: Passed, Unamended (Y: 5 N: 0 NV: 0 Abs: 2) [PASS]
2022-03-23 - Senate - Senate Health: Passed, With Amendments (Y: 5 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2022-04-19HouseReport adopted; referred to the committee(s) on CPC with Representative(s) Branco voting aye with reservations; none voting no (0) and Representative(s) Hashimoto, McKelvey, Ward excused (3).
2022-04-19HouseReported from HHH (Stand. Com. Rep. No. 2083-22), recommending referral to CPC.
2022-04-14HouseThe committees on HHH recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 5 Ayes: Representative(s) Yamane, Tam, Kapela, Nishimoto, Ward; Ayes with reservations: none; Noes: none; and 2 Excused: Representative(s) Gates, Har.
2022-04-11HouseResolution scheduled to be heard by HHH on Thursday, 04-14-22 9:00AM in conference room 329 Via Videoconference.
2022-04-04HouseReferred to HHH, CPC, referral sheet 42
2022-03-31HouseReceived from Senate (Sen. Com. No. 564) in amended form (SD 1).
2022-03-31SenateReport and Resolution Adopted, as amended (SD 1). Transmitted to House.
2022-03-30SenateOne Day Notice 03-31-22.
2022-03-30SenateReported from HTH (Stand. Com. Rep. No. 3527) with recommendation of adoption, as amended (SD 1).
2022-03-23SenateThe committee(s) on HTH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HTH were as follows: 5 Aye(s): Senator(s) Keohokalole, Baker, San Buenaventura; Aye(s) with reservations: Senator(s) Moriwaki, Fevella ; 0 No(es): none; and 0 Excused: none.
2022-03-18SenateThe committee(s) on HTH has scheduled a public hearing on 03-23-22 1:30PM; Conference Room 225 & Videoconference.
2022-03-16SenateReferred to HTH.
2022-03-11SenateOffered.

Same As/Similar To

SCR100 (Carry Over) 2021-04-08 - Report adopted; referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and Representative(s) McDermott excused (1).
SR88 (Same As) 2022-06-06 - Certified copies of resolutions sent, 06/06/22.

Subjects


Hawaii State Sources


Bill Comments

feedback